Hellman Jordan Management CO Inc Magenta Therapeutics, Inc. Transaction History
Hellman Jordan Management CO Inc
- $58.9 Million
- Q4 2022
A detailed history of Hellman Jordan Management CO Inc transactions in Magenta Therapeutics, Inc. stock. As of the latest transaction made, Hellman Jordan Management CO Inc holds 441,125 shares of MGTA stock, worth $0. This represents 0.3% of its overall portfolio holdings.
Number of Shares
441,125
Previous 181,964
142.42%
Holding current value
$0
Previous $257,000
32.3%
% of portfolio
0.3%
Previous 0.45%
Shares
3 transactions
Others Institutions Holding MGTA
# of Institutions
2Shares Held
442KCall Options Held
0Put Options Held
0About Magenta Therapeutics, Inc.
- Ticker MGTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,890,500
- Description
- Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...